Profound primary prevention of liver cancer following a natural experiment in China: A 50‐year perspective and public health implications
- 21 September 2024
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 156 (4) , 756-763
Abstract
Liver cancer causes upwards of 1 million cancer deaths annually and is projected to rise by at least 55% over the next 15 years. Two of the major risk factors contributing to liver cancer have been well documented by multiple epidemiologic studies and the hepatitis B virus (HBV) and aflatoxin show a synergy that increases by more than 8‐fold the risk of liver cancer relative to HBV alone. Using the population‐based cancer registry established by the Qidong Liver Cancer Institute in 1972 and aflatoxin‐specific biomarkers, we document that reduction of aflatoxin exposure has likely contributed to a nearly 70% decline in age‐standardized liver cancer incidence over the past 30 years despite an unchanging prevalence of HBV infection in cases. A natural experiment of economic reform in the 1980s drove a rapid switch from consumption of heavily contaminated corn to minimally, if any, contaminated rice and subsequent dietary diversity. Aflatoxin consumption appears to accelerate the time to liver cancer diagnosis; lowering exposure to this carcinogen adds years of life before a cancer diagnosis. Thus, in 1990 the median age of diagnosis was 48 years, while increasing to 67 years by 2021. These findings have important translational public health implications since up to 5 billion people worldwide might be routinely exposed to dietary aflatoxin, especially in societies using corn as the staple food. Interventions against aflatoxin are an achievable outcome leading to a reduction in liver cancer incidence and years of delay of its nearly always fatal diagnosis.Keywords
Funding Information
- Science and Technology Project of Nantong City (MS22019008)
- National Cancer Institute (P30 CA006973, R35 CA197222)
- Project 333 of Jiangsu Province (BRA2019030)
This publication has 38 references indexed in Scilit:
- Association of Nationwide Hepatitis B Vaccination and Antiviral Therapy Programs With End-Stage Liver Disease Burden in TaiwanJAMA Network Open, 2022
- Estimated Projection of US Cancer Incidence and Death to 2040JAMA Network Open, 2021
- Epidemiology of Hepatocellular CarcinomaHepatology, 2020
- HPV Vaccination and the Risk of Invasive Cervical CancerNew England Journal of Medicine, 2020
- Cancer registration in China and its role in cancer prevention and controlThe Lancet Oncology, 2020
- Serum concentrations of an aflatoxin-albumin adduct in the National Health and Nutrition Examination Survey (NHANES) 1999–2000Clinica Chimica Acta, 2013
- Carcinogenic effects of low dietary levels of aflatoxin B1 in ratsFood and Cosmetics Toxicology, 2002
- Aflatoxin exposure and risk of hepatocellular carcinoma in TaiwanInternational Journal of Cancer, 1996
- Elevated Aflatoxin Exposure and Increased Risk of Hepatocellular CarcinomaHepatology, 1996
- Urinary aflatoxin biomarkers and risk of hepatocellular carcinomaThe Lancet, 1992